{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import sys, time, json\n",
    "import pandas as pd\n",
    "import re\n",
    "from glob import glob\n",
    "\n",
    "import altair as alt\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "import scipy as sp"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>GeneSymbol</th>\n",
       "      <th>Statements</th>\n",
       "      <th>API_3x</th>\n",
       "      <th>API_5x</th>\n",
       "      <th>Manual_US</th>\n",
       "      <th>Manual_Thailand</th>\n",
       "      <th>Manual_Qatar</th>\n",
       "      <th>Claude-3</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>DDX58</td>\n",
       "      <td>a. Association with type I interferon responses</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>10.0</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>10.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>DDX58</td>\n",
       "      <td>b. Association with type II interferon responses</td>\n",
       "      <td>3.666667</td>\n",
       "      <td>5.8</td>\n",
       "      <td>5.666667</td>\n",
       "      <td>4.333333</td>\n",
       "      <td>3.333333</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>DDX58</td>\n",
       "      <td>c. Association with type III interferon responses</td>\n",
       "      <td>5.666667</td>\n",
       "      <td>6.2</td>\n",
       "      <td>7.333333</td>\n",
       "      <td>7.666667</td>\n",
       "      <td>5.333333</td>\n",
       "      <td>7.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>DDX58</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>8.666667</td>\n",
       "      <td>8.4</td>\n",
       "      <td>8.666667</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>DDX58</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>1.666667</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>2.333333</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0 GeneSymbol                                         Statements  \\\n",
       "0           0      DDX58    a. Association with type I interferon responses   \n",
       "1           1      DDX58   b. Association with type II interferon responses   \n",
       "2           2      DDX58  c. Association with type III interferon responses   \n",
       "3           3      DDX58  d. Relevance to circulating leukocytes immune ...   \n",
       "4           4      DDX58        e. Used as a biomarker in clinical settings   \n",
       "\n",
       "      API_3x  API_5x  Manual_US  Manual_Thailand  Manual_Qatar  Claude-3  \n",
       "0  10.000000    10.0  10.000000        10.000000      9.000000      10.0  \n",
       "1   3.666667     5.8   5.666667         4.333333      3.333333       4.0  \n",
       "2   5.666667     6.2   7.333333         7.666667      5.333333       7.0  \n",
       "3   8.666667     8.4   8.666667         6.000000      6.000000       8.0  \n",
       "4   1.666667     3.0   6.000000         2.333333      2.000000       3.0  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "benchmarking_m10_1=pd.read_csv(\"../data/openAI_result_curated/Interferone/Benchmarking_M10.1.csv.gz\",compression=\"gzip\")\n",
    "benchmarking_m10_1.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['a. Association with type I interferon responses',\n",
       "       'b. Association with type II interferon responses',\n",
       "       'c. Association with type III interferon responses',\n",
       "       'd. Relevance to circulating leukocytes immune biology',\n",
       "       'e. Used as a biomarker in clinical settings',\n",
       "       'f. Potential value as a blood transcriptional biomarker',\n",
       "       'g. Known drug target',\n",
       "       'h. Therapeutically relevant for immune system diseases'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "benchmarking_m10_1.Statements.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "## question color\n",
    "q_color = {'a. Association with type I interferon responses':'#de2d26',\n",
    "       'b. Association with type II interferon responses':'#fc9272',\n",
    "       'c. Association with type III interferon responses':'#fee5d9',\n",
    "       'd. Relevance to circulating leukocytes immune biology':'#756bb1',\n",
    "       'e. Used as a biomarker in clinical settings':'#74c476',\n",
    "       'f. Potential value as a blood transcriptional biomarker':'#c7e9c0',\n",
    "       'g. Known drug target':'#c994c7',\n",
    "       'h. Therapeutically relevant for immune system diseases':'#dd1c77'}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-0510d240238f496c962c44a82502d7f7.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-0510d240238f496c962c44a82502d7f7.vega-embed details,\n",
       "  #altair-viz-0510d240238f496c962c44a82502d7f7.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-0510d240238f496c962c44a82502d7f7\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-0510d240238f496c962c44a82502d7f7\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-0510d240238f496c962c44a82502d7f7\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.16.3?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.16.3\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300}}, \"data\": {\"name\": \"data-1c4515abdc5d02b93649b240a6e4d415\"}, \"mark\": {\"type\": \"rect\"}, \"encoding\": {\"color\": {\"field\": \"pearsonCorr\", \"legend\": {\"title\": \"Pearson Correlation\", \"titleOrient\": \"right\"}, \"scale\": {\"clamp\": true, \"scheme\": \"tealblues\"}, \"type\": \"quantitative\"}, \"tooltip\": [{\"field\": \"pearsonCorr\", \"type\": \"quantitative\"}], \"x\": {\"axis\": {\"labelFontSize\": 14, \"title\": \"\"}, \"field\": \"callMode1\", \"type\": \"nominal\"}, \"y\": {\"axis\": {\"labelFontSize\": 14, \"title\": \"\"}, \"field\": \"callMode2\", \"type\": \"nominal\"}}, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.16.3.json\", \"datasets\": {\"data-1c4515abdc5d02b93649b240a6e4d415\": [{\"callMode1\": \"API_3x\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 1.0}, {\"callMode1\": \"API_3x\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 0.9602458183904526}, {\"callMode1\": \"API_3x\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 0.8171444709779568}, {\"callMode1\": \"API_3x\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 0.7909570120417553}, {\"callMode1\": \"API_3x\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 0.9204377742294511}, {\"callMode1\": \"API_3x\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 0.8958931210999}, {\"callMode1\": \"API_5x\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 0.9602458183904526}, {\"callMode1\": \"API_5x\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 1.0}, {\"callMode1\": \"API_5x\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 0.8431006104312841}, {\"callMode1\": \"API_5x\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 0.8070111526689699}, {\"callMode1\": \"API_5x\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 0.9303716980787275}, {\"callMode1\": \"API_5x\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 0.8938540327537156}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 0.8171444709779568}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 0.8431006104312841}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 1.0}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 0.9195603541951037}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 0.8883526236385488}, {\"callMode1\": \"Manual_US\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 0.8436844516448787}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 0.7909570120417553}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 0.8070111526689699}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 0.9195603541951037}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 1.0}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 0.8749595821292742}, {\"callMode1\": \"Manual_Thailand\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 0.850782146590827}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 0.9204377742294511}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 0.9303716980787275}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 0.8883526236385488}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 0.8749595821292742}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 1.0}, {\"callMode1\": \"Manual_Qatar\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 0.87714880370709}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"API_3x\", \"pearsonCorr\": 0.8958931210999}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"API_5x\", \"pearsonCorr\": 0.8938540327537156}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"Manual_US\", \"pearsonCorr\": 0.8436844516448787}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"Manual_Thailand\", \"pearsonCorr\": 0.850782146590827}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"Manual_Qatar\", \"pearsonCorr\": 0.87714880370709}, {\"callMode1\": \"Claude-3\", \"callMode2\": \"Claude-3\", \"pearsonCorr\": 1.0}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.Chart(...)"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "corr_inter = benchmarking_m10_1[['API_3x', 'API_5x', 'Manual_US',\n",
    "       'Manual_Thailand', 'Manual_Qatar', 'Claude-3']].corr()\n",
    "\n",
    "corr_interX = corr_inter.unstack().reset_index().rename({'level_0':'callMode1','level_1':'callMode2',0:'pearsonCorr'},axis=1)\n",
    "\n",
    "alt.Chart(corr_interX).mark_rect().encode(\n",
    "    x=alt.X(\"callMode1\",axis=alt.Axis(title='',labelFontSize=14)),\n",
    "    y=alt.Y(\"callMode2\",axis=alt.Axis(title='',labelFontSize=14)),\n",
    "    color=alt.Color('pearsonCorr',scale=alt.Scale(scheme=\"tealblues\",clamp=True),legend=alt.Legend(title=\"Pearson Correlation\",titleOrient=\"right\")),\n",
    "    tooltip=['pearsonCorr']\n",
    "\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "import itertools\n",
    "\n",
    "mode_pair = list(itertools.combinations(['API_3x', 'API_5x', 'Manual_US',\n",
    "       'Manual_Thailand', 'Manual_Qatar', 'Claude-3'],2))\n",
    "\n",
    "statement_rel = pd.DataFrame(index=benchmarking_m10_1.Statements.unique())\n",
    "for kname, kgrp in benchmarking_m10_1.groupby(\"Statements\"):\n",
    "    for kpair in mode_pair:\n",
    "        kapr_name = \":\".join(kpair)\n",
    "        col1 = kgrp[kpair[0]].values\n",
    "        col2 = kgrp[kpair[1]].values\n",
    "        r, p = sp.stats.pearsonr(col1,col2)\n",
    "        statement_rel.loc[kname,kapr_name] = round(r,2)\n",
    "        statement_rel.loc[kname, kapr_name+\"_p\"] = p"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "statement_rel.to_csv(\"../data/openAI_result_curated/Interferone/Benchmarking_M10.1_scoreCorr.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>modePair</th>\n",
       "      <th>statements</th>\n",
       "      <th>pearson_r</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>a. Association with type I interferon responses</td>\n",
       "      <td>0.98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>b. Association with type II interferon responses</td>\n",
       "      <td>0.95</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>c. Association with type III interferon responses</td>\n",
       "      <td>0.93</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>0.97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>0.87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>Manual_Qatar:Claude-3</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>0.90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>Manual_Qatar:Claude-3</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>0.68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Manual_Qatar:Claude-3</td>\n",
       "      <td>f. Potential value as a blood transcriptional ...</td>\n",
       "      <td>0.90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>Manual_Qatar:Claude-3</td>\n",
       "      <td>g. Known drug target</td>\n",
       "      <td>0.73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Manual_Qatar:Claude-3</td>\n",
       "      <td>h. Therapeutically relevant for immune system ...</td>\n",
       "      <td>0.94</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>120 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                  modePair                                         statements  \\\n",
       "0            API_3x:API_5x    a. Association with type I interferon responses   \n",
       "1            API_3x:API_5x   b. Association with type II interferon responses   \n",
       "2            API_3x:API_5x  c. Association with type III interferon responses   \n",
       "3            API_3x:API_5x  d. Relevance to circulating leukocytes immune ...   \n",
       "4            API_3x:API_5x        e. Used as a biomarker in clinical settings   \n",
       "..                     ...                                                ...   \n",
       "115  Manual_Qatar:Claude-3  d. Relevance to circulating leukocytes immune ...   \n",
       "116  Manual_Qatar:Claude-3        e. Used as a biomarker in clinical settings   \n",
       "117  Manual_Qatar:Claude-3  f. Potential value as a blood transcriptional ...   \n",
       "118  Manual_Qatar:Claude-3                               g. Known drug target   \n",
       "119  Manual_Qatar:Claude-3  h. Therapeutically relevant for immune system ...   \n",
       "\n",
       "     pearson_r  \n",
       "0         0.98  \n",
       "1         0.95  \n",
       "2         0.93  \n",
       "3         0.97  \n",
       "4         0.87  \n",
       "..         ...  \n",
       "115       0.90  \n",
       "116       0.68  \n",
       "117       0.90  \n",
       "118       0.73  \n",
       "119       0.94  \n",
       "\n",
       "[120 rows x 3 columns]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "statement_relPT = statement_rel[statement_rel.columns[~statement_rel.columns.str.endswith(\"p\")]].unstack().reset_index().rename({'level_0':'modePair','level_1':'statements',0:'pearson_r'},axis=1)\n",
    "statement_relPT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>modePair</th>\n",
       "      <th>statements</th>\n",
       "      <th>pearson_r</th>\n",
       "      <th>statement_key</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>a. Association with type I interferon responses</td>\n",
       "      <td>0.98</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>b. Association with type II interferon responses</td>\n",
       "      <td>0.95</td>\n",
       "      <td>b</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>c. Association with type III interferon responses</td>\n",
       "      <td>0.93</td>\n",
       "      <td>c</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>0.97</td>\n",
       "      <td>d</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>API_3x:API_5x</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>0.87</td>\n",
       "      <td>e</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        modePair                                         statements  \\\n",
       "0  API_3x:API_5x    a. Association with type I interferon responses   \n",
       "1  API_3x:API_5x   b. Association with type II interferon responses   \n",
       "2  API_3x:API_5x  c. Association with type III interferon responses   \n",
       "3  API_3x:API_5x  d. Relevance to circulating leukocytes immune ...   \n",
       "4  API_3x:API_5x        e. Used as a biomarker in clinical settings   \n",
       "\n",
       "   pearson_r statement_key  \n",
       "0       0.98             a  \n",
       "1       0.95             b  \n",
       "2       0.93             c  \n",
       "3       0.97             d  \n",
       "4       0.87             e  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "statement_relPT['statement_key'] = [i[0] for i in statement_relPT.statements.values]\n",
    "statement_relPT.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-5ed42cde58434453b48301d8a194aa8f.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-5ed42cde58434453b48301d8a194aa8f.vega-embed details,\n",
       "  #altair-viz-5ed42cde58434453b48301d8a194aa8f.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-5ed42cde58434453b48301d8a194aa8f\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-5ed42cde58434453b48301d8a194aa8f\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-5ed42cde58434453b48301d8a194aa8f\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.16.3?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.16.3\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300, \"strokeWidth\": 0}, \"axis\": {\"domain\": false, \"grid\": false}}, \"data\": {\"name\": \"data-62240277cec4a264da38c63a4d81096b\"}, \"mark\": {\"type\": \"rect\"}, \"encoding\": {\"color\": {\"field\": \"pearson_r\", \"legend\": {\"title\": \"Pearson Correlation\", \"titleOrient\": \"right\"}, \"scale\": {\"clamp\": true, \"scheme\": \"blueorange\"}, \"type\": \"quantitative\"}, \"tooltip\": [{\"field\": \"modePair\", \"type\": \"nominal\"}, {\"field\": \"statements\", \"type\": \"nominal\"}, {\"field\": \"pearson_r\", \"type\": \"quantitative\"}], \"x\": {\"axis\": {\"labelFontSize\": 14, \"labelLimit\": 500, \"title\": \"\"}, \"field\": \"modePair\", \"type\": \"nominal\"}, \"y\": {\"axis\": {\"labelFontSize\": 14, \"labelLimit\": 20, \"title\": \"Statement Key\"}, \"field\": \"statement_key\", \"type\": \"nominal\"}}, \"height\": 150, \"width\": 300, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.16.3.json\", \"datasets\": {\"data-62240277cec4a264da38c63a4d81096b\": [{\"modePair\": \"API_3x:API_5x\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.98, \"statement_key\": \"a\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"b\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.93, \"statement_key\": \"c\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.97, \"statement_key\": \"d\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.87, \"statement_key\": \"e\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.84, \"statement_key\": \"f\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.97, \"statement_key\": \"g\"}, {\"modePair\": \"API_3x:API_5x\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.97, \"statement_key\": \"h\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.96, \"statement_key\": \"a\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.92, \"statement_key\": \"b\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.88, \"statement_key\": \"c\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.95, \"statement_key\": \"d\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.73, \"statement_key\": \"e\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.89, \"statement_key\": \"f\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.77, \"statement_key\": \"g\"}, {\"modePair\": \"API_3x:Manual_US\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.95, \"statement_key\": \"h\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"a\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.89, \"statement_key\": \"b\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.83, \"statement_key\": \"c\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.89, \"statement_key\": \"d\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.57, \"statement_key\": \"e\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.78, \"statement_key\": \"f\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.73, \"statement_key\": \"g\"}, {\"modePair\": \"API_3x:Manual_Thailand\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.9, \"statement_key\": \"h\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.97, \"statement_key\": \"a\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.93, \"statement_key\": \"b\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.84, \"statement_key\": \"c\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.92, \"statement_key\": \"d\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.81, \"statement_key\": \"e\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.85, \"statement_key\": \"f\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.79, \"statement_key\": \"g\"}, {\"modePair\": \"API_3x:Manual_Qatar\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.94, \"statement_key\": \"h\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.9, \"statement_key\": \"a\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.79, \"statement_key\": \"b\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.85, \"statement_key\": \"c\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.9, \"statement_key\": \"d\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.6, \"statement_key\": \"e\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.84, \"statement_key\": \"f\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.68, \"statement_key\": \"g\"}, {\"modePair\": \"API_3x:Claude-3\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.93, \"statement_key\": \"h\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"a\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"b\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.93, \"statement_key\": \"c\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.98, \"statement_key\": \"d\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.88, \"statement_key\": \"e\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.93, \"statement_key\": \"f\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.78, \"statement_key\": \"g\"}, {\"modePair\": \"API_5x:Manual_US\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.96, \"statement_key\": \"h\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"a\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.89, \"statement_key\": \"b\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.88, \"statement_key\": \"c\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.85, \"statement_key\": \"d\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.56, \"statement_key\": \"e\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.81, \"statement_key\": \"f\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.73, \"statement_key\": \"g\"}, {\"modePair\": \"API_5x:Manual_Thailand\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.88, \"statement_key\": \"h\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.96, \"statement_key\": \"a\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.93, \"statement_key\": \"b\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.9, \"statement_key\": \"c\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.92, \"statement_key\": \"d\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.92, \"statement_key\": \"e\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.92, \"statement_key\": \"f\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.78, \"statement_key\": \"g\"}, {\"modePair\": \"API_5x:Manual_Qatar\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.97, \"statement_key\": \"h\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.89, \"statement_key\": \"a\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.77, \"statement_key\": \"b\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.88, \"statement_key\": \"c\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.94, \"statement_key\": \"d\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.64, \"statement_key\": \"e\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.88, \"statement_key\": \"f\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.7, \"statement_key\": \"g\"}, {\"modePair\": \"API_5x:Claude-3\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.92, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.97, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.94, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.98, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.89, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.71, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.93, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.87, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_US:Manual_Thailand\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.94, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.98, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.96, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.91, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.94, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.83, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.93, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.9, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_US:Manual_Qatar\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.96, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.84, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.79, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.84, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.96, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.75, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.95, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.84, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_US:Claude-3\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.96, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.95, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.93, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.91, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.91, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.61, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.88, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.86, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_Thailand:Manual_Qatar\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.88, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.86, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.89, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.83, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.88, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.74, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.94, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.77, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_Thailand:Claude-3\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.92, \"statement_key\": \"h\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"a. Association with type I interferon responses\", \"pearson_r\": 0.82, \"statement_key\": \"a\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"b. Association with type II interferon responses\", \"pearson_r\": 0.76, \"statement_key\": \"b\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"c. Association with type III interferon responses\", \"pearson_r\": 0.83, \"statement_key\": \"c\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"d. Relevance to circulating leukocytes immune biology\", \"pearson_r\": 0.9, \"statement_key\": \"d\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"e. Used as a biomarker in clinical settings\", \"pearson_r\": 0.68, \"statement_key\": \"e\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"f. Potential value as a blood transcriptional biomarker\", \"pearson_r\": 0.9, \"statement_key\": \"f\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"g. Known drug target\", \"pearson_r\": 0.73, \"statement_key\": \"g\"}, {\"modePair\": \"Manual_Qatar:Claude-3\", \"statements\": \"h. Therapeutically relevant for immune system diseases\", \"pearson_r\": 0.94, \"statement_key\": \"h\"}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.Chart(...)"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "alt.Chart(statement_relPT,width=300, height=150).mark_rect().encode(\n",
    "        x=alt.X(\"modePair\",axis=alt.Axis(labelFontSize=14,labelLimit=500,title='')),\n",
    "        y=alt.Y(\"statement_key\",axis=alt.Axis(labelFontSize=14,labelLimit=20,title='Statement Key')),\n",
    "        color=alt.Color('pearson_r',scale=alt.Scale(scheme='blueorange',clamp=True),legend=alt.Legend(title=\"Pearson Correlation\",titleOrient=\"right\")),\n",
    "        tooltip=['modePair','statements','pearson_r']\n",
    "    ).configure_view(strokeWidth=0).configure_axis(grid=False, domain=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>modePair</th>\n",
       "      <th>statements</th>\n",
       "      <th>pearson_r</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>API_3x:API_5x_r</td>\n",
       "      <td>a. Association with type I interferon responses</td>\n",
       "      <td>0.98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>API_3x:API_5x_r</td>\n",
       "      <td>b. Association with type II interferon responses</td>\n",
       "      <td>0.95</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>API_3x:API_5x_r</td>\n",
       "      <td>c. Association with type III interferon responses</td>\n",
       "      <td>0.93</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>API_3x:API_5x_r</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>0.97</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>API_3x:API_5x_r</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>0.87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>Manual_Qatar:Claude-3_r</td>\n",
       "      <td>d. Relevance to circulating leukocytes immune ...</td>\n",
       "      <td>0.90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>Manual_Qatar:Claude-3_r</td>\n",
       "      <td>e. Used as a biomarker in clinical settings</td>\n",
       "      <td>0.68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>Manual_Qatar:Claude-3_r</td>\n",
       "      <td>f. Potential value as a blood transcriptional ...</td>\n",
       "      <td>0.90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>Manual_Qatar:Claude-3_r</td>\n",
       "      <td>g. Known drug target</td>\n",
       "      <td>0.73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Manual_Qatar:Claude-3_r</td>\n",
       "      <td>h. Therapeutically relevant for immune system ...</td>\n",
       "      <td>0.94</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>120 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                    modePair  \\\n",
       "0            API_3x:API_5x_r   \n",
       "1            API_3x:API_5x_r   \n",
       "2            API_3x:API_5x_r   \n",
       "3            API_3x:API_5x_r   \n",
       "4            API_3x:API_5x_r   \n",
       "..                       ...   \n",
       "115  Manual_Qatar:Claude-3_r   \n",
       "116  Manual_Qatar:Claude-3_r   \n",
       "117  Manual_Qatar:Claude-3_r   \n",
       "118  Manual_Qatar:Claude-3_r   \n",
       "119  Manual_Qatar:Claude-3_r   \n",
       "\n",
       "                                            statements  pearson_r  \n",
       "0      a. Association with type I interferon responses       0.98  \n",
       "1     b. Association with type II interferon responses       0.95  \n",
       "2    c. Association with type III interferon responses       0.93  \n",
       "3    d. Relevance to circulating leukocytes immune ...       0.97  \n",
       "4          e. Used as a biomarker in clinical settings       0.87  \n",
       "..                                                 ...        ...  \n",
       "115  d. Relevance to circulating leukocytes immune ...       0.90  \n",
       "116        e. Used as a biomarker in clinical settings       0.68  \n",
       "117  f. Potential value as a blood transcriptional ...       0.90  \n",
       "118                               g. Known drug target       0.73  \n",
       "119  h. Therapeutically relevant for immune system ...       0.94  \n",
       "\n",
       "[120 rows x 3 columns]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "statement_relPT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "    \n",
    "def get_lmplot(df,x,y,height=3, aspect=1):\n",
    "    g = sns.lmplot(x=x, y=y, data=df, height=height, aspect=aspect,hue=\"Statements\")\n",
    "\n",
    "    def annotate(data, **kws):\n",
    "        r, p = sp.stats.pearsonr(data[x], data[y])\n",
    "        ax = plt.gca()\n",
    "        ax.text(.05, .8, 'r={:.2f}, p={:.2g}'.format(r, p),\n",
    "                transform=ax.transAxes)\n",
    "        r, p = sp.stats.pearsonr(data[x], data[y])\n",
    "    return g.map_dataframe(annotate)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "def giveCorrPlot(x_data, y_data):\n",
    "    r, p = sp.stats.pearsonr(benchmarking_m10_1[x_data], benchmarking_m10_1[y_data])\n",
    "\n",
    "    c = alt.Chart(benchmarking_m10_1,width=150,height=180).mark_point(filled=True).encode(\n",
    "        x=alt.X(x_data,axis=alt.Axis(labelFontSize=14,)),\n",
    "        y=alt.Y(y_data,axis=alt.Axis(labelFontSize=14,)),\n",
    "        color=alt.Color(\"Statements\",scale=alt.Scale(domain=list(q_color.keys()),range=list(q_color.values())),legend=alt.Legend(labelLimit=500)),\n",
    "        tooltip=['GeneSymbol','Statements']\n",
    "    )\n",
    "\n",
    "    text = alt.Chart().mark_text(\n",
    "        align=\"left\",\n",
    "        baseline=\"top\",\n",
    "        fontSize=12,\n",
    "        fontWeight='normal',\n",
    "        color='black'\n",
    "    ).encode(\n",
    "        x=alt.value(10),  # pixels from left\n",
    "        y=alt.value(5),  # pixels from top\n",
    "        text=alt.value([ 'r={:.2f}, p={:.2g}'.format(r, p),])\n",
    "    )\n",
    "\n",
    "    return c+text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "c1 = giveCorrPlot('API_3x','API_5x')\n",
    "c2 =  giveCorrPlot('API_3x','Manual_Qatar')\n",
    "c3 =  giveCorrPlot('API_3x','Manual_US')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-4c33c9183dd74781b426180970c42e74.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-4c33c9183dd74781b426180970c42e74.vega-embed details,\n",
       "  #altair-viz-4c33c9183dd74781b426180970c42e74.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-4c33c9183dd74781b426180970c42e74\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-4c33c9183dd74781b426180970c42e74\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-4c33c9183dd74781b426180970c42e74\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.16.3?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.16.3\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300, \"strokeWidth\": 3}, \"axis\": {\"domain\": false, \"grid\": false}}, \"hconcat\": [{\"layer\": [{\"data\": {\"name\": \"data-2d177fda36bb46ff3643c5aba7a48048\"}, \"mark\": {\"type\": \"point\", \"filled\": true}, \"encoding\": {\"color\": {\"field\": \"Statements\", \"legend\": {\"labelLimit\": 500}, \"scale\": {\"domain\": [\"a. Association with type I interferon responses\", \"b. Association with type II interferon responses\", \"c. Association with type III interferon responses\", \"d. Relevance to circulating leukocytes immune biology\", \"e. Used as a biomarker in clinical settings\", \"f. Potential value as a blood transcriptional biomarker\", \"g. Known drug target\", \"h. Therapeutically relevant for immune system diseases\"], \"range\": [\"#de2d26\", \"#fc9272\", \"#fee5d9\", \"#756bb1\", \"#74c476\", \"#c7e9c0\", \"#c994c7\", \"#dd1c77\"]}, \"type\": \"nominal\"}, \"tooltip\": [{\"field\": \"GeneSymbol\", \"type\": \"nominal\"}, {\"field\": \"Statements\", \"type\": \"nominal\"}], \"x\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"API_3x\", \"type\": \"quantitative\"}, \"y\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"API_5x\", \"type\": \"quantitative\"}}}, {\"data\": {\"name\": \"empty\"}, \"mark\": {\"type\": \"text\", \"align\": \"left\", \"baseline\": \"top\", \"color\": \"black\", \"fontSize\": 12, \"fontWeight\": \"normal\"}, \"encoding\": {\"text\": {\"value\": [\"r=0.96, p=6.6e-94\"]}, \"x\": {\"value\": 10}, \"y\": {\"value\": 5}}}], \"height\": 180, \"width\": 150}, {\"layer\": [{\"data\": {\"name\": \"data-2d177fda36bb46ff3643c5aba7a48048\"}, \"mark\": {\"type\": \"point\", \"filled\": true}, \"encoding\": {\"color\": {\"field\": \"Statements\", \"legend\": {\"labelLimit\": 500}, \"scale\": {\"domain\": [\"a. Association with type I interferon responses\", \"b. Association with type II interferon responses\", \"c. Association with type III interferon responses\", \"d. Relevance to circulating leukocytes immune biology\", \"e. Used as a biomarker in clinical settings\", \"f. Potential value as a blood transcriptional biomarker\", \"g. Known drug target\", \"h. Therapeutically relevant for immune system diseases\"], \"range\": [\"#de2d26\", \"#fc9272\", \"#fee5d9\", \"#756bb1\", \"#74c476\", \"#c7e9c0\", \"#c994c7\", \"#dd1c77\"]}, \"type\": \"nominal\"}, \"tooltip\": [{\"field\": \"GeneSymbol\", \"type\": \"nominal\"}, {\"field\": \"Statements\", \"type\": \"nominal\"}], \"x\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"API_3x\", \"type\": \"quantitative\"}, \"y\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"Manual_Qatar\", \"type\": \"quantitative\"}}}, {\"data\": {\"name\": \"empty\"}, \"mark\": {\"type\": \"text\", \"align\": \"left\", \"baseline\": \"top\", \"color\": \"black\", \"fontSize\": 12, \"fontWeight\": \"normal\"}, \"encoding\": {\"text\": {\"value\": [\"r=0.92, p=1.3e-69\"]}, \"x\": {\"value\": 10}, \"y\": {\"value\": 5}}}], \"height\": 180, \"width\": 150}, {\"layer\": [{\"data\": {\"name\": \"data-2d177fda36bb46ff3643c5aba7a48048\"}, \"mark\": {\"type\": \"point\", \"filled\": true}, \"encoding\": {\"color\": {\"field\": \"Statements\", \"legend\": {\"labelLimit\": 500}, \"scale\": {\"domain\": [\"a. Association with type I interferon responses\", \"b. Association with type II interferon responses\", \"c. Association with type III interferon responses\", \"d. Relevance to circulating leukocytes immune biology\", \"e. Used as a biomarker in clinical settings\", \"f. Potential value as a blood transcriptional biomarker\", \"g. Known drug target\", \"h. Therapeutically relevant for immune system diseases\"], \"range\": [\"#de2d26\", \"#fc9272\", \"#fee5d9\", \"#756bb1\", \"#74c476\", \"#c7e9c0\", \"#c994c7\", \"#dd1c77\"]}, \"type\": \"nominal\"}, \"tooltip\": [{\"field\": \"GeneSymbol\", \"type\": \"nominal\"}, {\"field\": \"Statements\", \"type\": \"nominal\"}], \"x\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"API_3x\", \"type\": \"quantitative\"}, \"y\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"Manual_US\", \"type\": \"quantitative\"}}}, {\"data\": {\"name\": \"empty\"}, \"mark\": {\"type\": \"text\", \"align\": \"left\", \"baseline\": \"top\", \"color\": \"black\", \"fontSize\": 12, \"fontWeight\": \"normal\"}, \"encoding\": {\"text\": {\"value\": [\"r=0.82, p=1.5e-41\"]}, \"x\": {\"value\": 10}, \"y\": {\"value\": 5}}}], \"height\": 180, \"width\": 150}], \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.16.3.json\", \"datasets\": {\"data-2d177fda36bb46ff3643c5aba7a48048\": [{\"Unnamed: 0\": 0, \"GeneSymbol\": \"DDX58\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 10.0, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 9.0, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 1, \"GeneSymbol\": \"DDX58\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 5.8, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 2, \"GeneSymbol\": \"DDX58\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 5.666666666666667, \"API_5x\": 6.2, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 3, \"GeneSymbol\": \"DDX58\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.666666666666666, \"API_5x\": 8.4, \"Manual_US\": 8.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 6.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 4, \"GeneSymbol\": \"DDX58\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 1.6666666666666667, \"API_5x\": 3.0, \"Manual_US\": 6.0, \"Manual_Thailand\": 2.333333333, \"Manual_Qatar\": 2.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 5, \"GeneSymbol\": \"DDX58\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 6.333333333333333, \"API_5x\": 6.0, \"Manual_US\": 7.0, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 3.66666667, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 6, \"GeneSymbol\": \"DDX58\", \"Statements\": \"g. Known drug target\", \"API_3x\": 3.3333333333333335, \"API_5x\": 4.0, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 7, \"GeneSymbol\": \"DDX58\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 8.333333333333334, \"API_5x\": 8.2, \"Manual_US\": 8.0, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 6.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 8, \"GeneSymbol\": \"DDX60\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 8.666666666666666, \"API_5x\": 8.4, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 8.333333333, \"Manual_Qatar\": 8.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 9, \"GeneSymbol\": \"DDX60\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 5.4, \"Manual_US\": 3.666666667, \"Manual_Thailand\": 3.0, \"Manual_Qatar\": 3.66666667, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 10, \"GeneSymbol\": \"DDX60\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.0, \"API_5x\": 5.6, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 11, \"GeneSymbol\": \"DDX60\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.0, \"API_5x\": 7.0, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 6.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 12, \"GeneSymbol\": \"DDX60\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 2.4, \"Manual_US\": 4.0, \"Manual_Thailand\": 2.333333333, \"Manual_Qatar\": 2.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 13, \"GeneSymbol\": \"DDX60\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.333333333333333, \"API_5x\": 5.6, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 5.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 14, \"GeneSymbol\": \"DDX60\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.0, \"API_5x\": 1.4, \"Manual_US\": 2.666666667, \"Manual_Thailand\": 3.333333333, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 15, \"GeneSymbol\": \"DDX60\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 5.666666666666667, \"API_5x\": 6.4, \"Manual_US\": 5.0, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 6.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 16, \"GeneSymbol\": \"DHX58\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 8.666666666666666, \"API_5x\": 8.2, \"Manual_US\": 7.0, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 8.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 17, \"GeneSymbol\": \"DHX58\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 5.8, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 2.666666667, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 18, \"GeneSymbol\": \"DHX58\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 5.6, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 19, \"GeneSymbol\": \"DHX58\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.0, \"API_5x\": 7.6, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 20, \"GeneSymbol\": \"DHX58\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 2.6, \"Manual_US\": 3.0, \"Manual_Thailand\": 1.666666667, \"Manual_Qatar\": 2.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 21, \"GeneSymbol\": \"DHX58\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.333333333333333, \"API_5x\": 5.2, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 3.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 22, \"GeneSymbol\": \"DHX58\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.3333333333333333, \"API_5x\": 1.6, \"Manual_US\": 2.333333333, \"Manual_Thailand\": 2.333333333, \"Manual_Qatar\": 2.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 23, \"GeneSymbol\": \"DHX58\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.0, \"API_5x\": 6.8, \"Manual_US\": 5.0, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 6.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 24, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 2.6666666666666665, \"API_5x\": 1.8, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 25, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 1.6666666666666667, \"API_5x\": 1.8, \"Manual_US\": 1.0, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 0.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 26, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 1.0, \"API_5x\": 1.2, \"Manual_US\": 1.0, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 0.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 27, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 4.666666666666667, \"API_5x\": 4.2, \"Manual_US\": 2.0, \"Manual_Thailand\": 2.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 28, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 0.6666666666666666, \"API_5x\": 0.8, \"Manual_US\": 1.0, \"Manual_Thailand\": 0.666666667, \"Manual_Qatar\": 0.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 29, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 3.6666666666666665, \"API_5x\": 3.2, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 1.666666667, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 30, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.0, \"API_5x\": 1.0, \"Manual_US\": 1.0, \"Manual_Thailand\": 1.333333333, \"Manual_Qatar\": 0.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 31, \"GeneSymbol\": \"FBXO6\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 2.6666666666666665, \"API_5x\": 2.6, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 1.333333333, \"Manual_Qatar\": 1.66666667, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 32, \"GeneSymbol\": \"GBP1\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 6.666666666666667, \"API_5x\": 6.4, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 33, \"GeneSymbol\": \"GBP1\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 9.0, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 9.333333333, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 34, \"GeneSymbol\": \"GBP1\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 4.666666666666667, \"API_5x\": 5.0, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 35, \"GeneSymbol\": \"GBP1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.0, \"API_5x\": 8.2, \"Manual_US\": 8.333333333, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 7.33333333, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 36, \"GeneSymbol\": \"GBP1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.6666666666666665, \"API_5x\": 2.8, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 37, \"GeneSymbol\": \"GBP1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.333333333333333, \"API_5x\": 5.4, \"Manual_US\": 7.0, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 38, \"GeneSymbol\": \"GBP1\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.6666666666666667, \"API_5x\": 1.8, \"Manual_US\": 3.333333333, \"Manual_Thailand\": 4.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 39, \"GeneSymbol\": \"GBP1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.666666666666667, \"API_5x\": 7.2, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 6.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 40, \"GeneSymbol\": \"GBP4\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 5.666666666666667, \"API_5x\": 6.0, \"Manual_US\": 3.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 41, \"GeneSymbol\": \"GBP4\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 6.333333333333333, \"API_5x\": 8.2, \"Manual_US\": 9.0, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 42, \"GeneSymbol\": \"GBP4\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 4.8, \"Manual_US\": 4.666666667, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 2.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 43, \"GeneSymbol\": \"GBP4\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 6.666666666666667, \"API_5x\": 7.4, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 6.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 44, \"GeneSymbol\": \"GBP4\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 2.2, \"Manual_US\": 4.0, \"Manual_Thailand\": 3.333333333, \"Manual_Qatar\": 1.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 45, \"GeneSymbol\": \"GBP4\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.0, \"API_5x\": 5.2, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 3.66666667, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 46, \"GeneSymbol\": \"GBP4\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.0, \"API_5x\": 1.2, \"Manual_US\": 2.333333333, \"Manual_Thailand\": 2.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 47, \"GeneSymbol\": \"GBP4\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 5.0, \"API_5x\": 6.0, \"Manual_US\": 6.0, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 5.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 48, \"GeneSymbol\": \"GBP5\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 6.666666666666667, \"API_5x\": 6.6, \"Manual_US\": 3.666666667, \"Manual_Thailand\": 4.0, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 49, \"GeneSymbol\": \"GBP5\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 7.333333333333333, \"API_5x\": 8.2, \"Manual_US\": 9.666666667, \"Manual_Thailand\": 9.333333333, \"Manual_Qatar\": 8.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 50, \"GeneSymbol\": \"GBP5\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 4.333333333333333, \"API_5x\": 5.0, \"Manual_US\": 4.666666667, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 51, \"GeneSymbol\": \"GBP5\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.333333333333334, \"API_5x\": 8.0, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 52, \"GeneSymbol\": \"GBP5\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.3333333333333335, \"API_5x\": 2.8, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 53, \"GeneSymbol\": \"GBP5\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.0, \"API_5x\": 5.2, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 5.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 54, \"GeneSymbol\": \"GBP5\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.3333333333333333, \"API_5x\": 1.6, \"Manual_US\": 2.666666667, \"Manual_Thailand\": 3.666666667, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 55, \"GeneSymbol\": \"GBP5\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.666666666666667, \"API_5x\": 6.8, \"Manual_US\": 7.0, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 6.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 56, \"GeneSymbol\": \"IFI35\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 8.0, \"API_5x\": 7.2, \"Manual_US\": 8.0, \"Manual_Thailand\": 8.333333333, \"Manual_Qatar\": 7.33333333, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 57, \"GeneSymbol\": \"IFI35\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 5.0, \"API_5x\": 6.0, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 58, \"GeneSymbol\": \"IFI35\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.0, \"API_5x\": 4.2, \"Manual_US\": 5.0, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 2.33333333, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 59, \"GeneSymbol\": \"IFI35\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.0, \"API_5x\": 6.8, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 60, \"GeneSymbol\": \"IFI35\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 2.4, \"Manual_US\": 4.666666667, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 1.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 61, \"GeneSymbol\": \"IFI35\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 6.0, \"API_5x\": 5.2, \"Manual_US\": 6.0, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 62, \"GeneSymbol\": \"IFI35\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.0, \"API_5x\": 1.2, \"Manual_US\": 3.0, \"Manual_Thailand\": 2.666666667, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 63, \"GeneSymbol\": \"IFI35\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 5.0, \"API_5x\": 6.0, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 64, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.333333333333334, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 9.33333333, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 65, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.0, \"API_5x\": 5.0, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 66, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 5.333333333333333, \"API_5x\": 5.6, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 67, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.0, \"API_5x\": 8.4, \"Manual_US\": 8.666666667, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 68, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.3333333333333335, \"API_5x\": 3.0, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 69, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.0, \"API_5x\": 6.4, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 70, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"g. Known drug target\", \"API_3x\": 2.3333333333333335, \"API_5x\": 2.0, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 5.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 71, \"GeneSymbol\": \"IFIH1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 7.0, \"API_5x\": 7.6, \"Manual_US\": 8.333333333, \"Manual_Thailand\": 8.333333333, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 72, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.333333333333334, \"API_5x\": 9.0, \"Manual_US\": 9.333333333, \"Manual_Thailand\": 9.333333333, \"Manual_Qatar\": 9.0, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 73, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 5.0, \"API_5x\": 6.6, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 74, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 5.0, \"API_5x\": 6.2, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 5.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 75, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.666666666666667, \"API_5x\": 7.8, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 76, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 3.0, \"API_5x\": 3.0, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 2.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 77, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 6.0, \"API_5x\": 5.4, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 78, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"g. Known drug target\", \"API_3x\": 2.0, \"API_5x\": 1.8, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 3.333333333, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 79, \"GeneSymbol\": \"IFIT2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.666666666666667, \"API_5x\": 6.6, \"Manual_US\": 7.0, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 6.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 80, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.0, \"API_5x\": 9.0, \"Manual_US\": 9.333333333, \"Manual_Thailand\": 9.0, \"Manual_Qatar\": 8.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 81, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 4.0, \"API_5x\": 6.0, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 82, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 4.333333333333333, \"API_5x\": 5.8, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 83, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.0, \"API_5x\": 7.8, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 5.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 84, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 3.2, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 2.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 85, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.666666666666667, \"API_5x\": 5.8, \"Manual_US\": 7.0, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 86, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.6666666666666667, \"API_5x\": 2.0, \"Manual_US\": 3.333333333, \"Manual_Thailand\": 2.666666667, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 87, \"GeneSymbol\": \"IFIT5\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.0, \"API_5x\": 6.8, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 6.0, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 88, \"GeneSymbol\": \"IRF7\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 10.0, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 10.0, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 89, \"GeneSymbol\": \"IRF7\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.0, \"API_5x\": 5.4, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 90, \"GeneSymbol\": \"IRF7\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 6.0, \"API_5x\": 7.2, \"Manual_US\": 8.0, \"Manual_Thailand\": 7.333333333, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 91, \"GeneSymbol\": \"IRF7\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.666666666666666, \"API_5x\": 8.8, \"Manual_US\": 9.0, \"Manual_Thailand\": 8.333333333, \"Manual_Qatar\": 8.0, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 92, \"GeneSymbol\": \"IRF7\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 4.0, \"API_5x\": 3.6, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 3.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 93, \"GeneSymbol\": \"IRF7\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 6.333333333333333, \"API_5x\": 6.4, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 94, \"GeneSymbol\": \"IRF7\", \"Statements\": \"g. Known drug target\", \"API_3x\": 2.0, \"API_5x\": 2.4, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 3.66666667, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 95, \"GeneSymbol\": \"IRF7\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 7.666666666666667, \"API_5x\": 7.8, \"Manual_US\": 8.333333333, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 7.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 96, \"GeneSymbol\": \"LAP3\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 3.0, \"API_5x\": 2.0, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 2.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 97, \"GeneSymbol\": \"LAP3\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 2.0, \"API_5x\": 2.0, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 2.666666667, \"Manual_Qatar\": 1.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 98, \"GeneSymbol\": \"LAP3\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 1.0, \"API_5x\": 1.0, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 2.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 99, \"GeneSymbol\": \"LAP3\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 5.0, \"API_5x\": 4.4, \"Manual_US\": 2.333333333, \"Manual_Thailand\": 4.0, \"Manual_Qatar\": 2.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 100, \"GeneSymbol\": \"LAP3\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 1.6666666666666667, \"API_5x\": 1.0, \"Manual_US\": 1.666666667, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 0.33333333, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 101, \"GeneSymbol\": \"LAP3\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 3.3333333333333335, \"API_5x\": 3.2, \"Manual_US\": 1.666666667, \"Manual_Thailand\": 3.0, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 102, \"GeneSymbol\": \"LAP3\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.3333333333333333, \"API_5x\": 1.6, \"Manual_US\": 2.0, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 0.66666667, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 103, \"GeneSymbol\": \"LAP3\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 3.0, \"API_5x\": 3.0, \"Manual_US\": 2.0, \"Manual_Thailand\": 4.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 104, \"GeneSymbol\": \"OAS2\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.666666666666666, \"API_5x\": 9.4, \"Manual_US\": 9.333333333, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 9.33333333, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 105, \"GeneSymbol\": \"OAS2\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 5.333333333333333, \"API_5x\": 7.4, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 5.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 106, \"GeneSymbol\": \"OAS2\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 5.0, \"API_5x\": 6.4, \"Manual_US\": 7.0, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 107, \"GeneSymbol\": \"OAS2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.333333333333334, \"API_5x\": 8.4, \"Manual_US\": 8.0, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 6.33333333, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 108, \"GeneSymbol\": \"OAS2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 3.0, \"API_5x\": 3.8, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 3.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 109, \"GeneSymbol\": \"OAS2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 7.0, \"API_5x\": 5.6, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 5.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 110, \"GeneSymbol\": \"OAS2\", \"Statements\": \"g. Known drug target\", \"API_3x\": 2.0, \"API_5x\": 2.6, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 111, \"GeneSymbol\": \"OAS2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 7.333333333333333, \"API_5x\": 7.2, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 7.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 112, \"GeneSymbol\": \"PARP12\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 7.666666666666667, \"API_5x\": 6.8, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 8.666666667, \"Manual_Qatar\": 6.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 113, \"GeneSymbol\": \"PARP12\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.6666666666666665, \"API_5x\": 5.2, \"Manual_US\": 4.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 114, \"GeneSymbol\": \"PARP12\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 2.3333333333333335, \"API_5x\": 4.0, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 3.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 115, \"GeneSymbol\": \"PARP12\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 6.333333333333333, \"API_5x\": 6.6, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 116, \"GeneSymbol\": \"PARP12\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 1.3333333333333333, \"API_5x\": 2.2, \"Manual_US\": 5.0, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 2.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 117, \"GeneSymbol\": \"PARP12\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.0, \"API_5x\": 5.0, \"Manual_US\": 6.0, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 118, \"GeneSymbol\": \"PARP12\", \"Statements\": \"g. Known drug target\", \"API_3x\": 2.6666666666666665, \"API_5x\": 2.4, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 4.0, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 119, \"GeneSymbol\": \"PARP12\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 4.666666666666667, \"API_5x\": 5.6, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 5.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 120, \"GeneSymbol\": \"PARP14\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 7.0, \"API_5x\": 6.4, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.333333333, \"Manual_Qatar\": 6.33333333, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 121, \"GeneSymbol\": \"PARP14\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 5.0, \"API_5x\": 5.2, \"Manual_US\": 5.0, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 122, \"GeneSymbol\": \"PARP14\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.3333333333333335, \"API_5x\": 3.8, \"Manual_US\": 4.333333333, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 123, \"GeneSymbol\": \"PARP14\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.0, \"API_5x\": 7.4, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 6.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 124, \"GeneSymbol\": \"PARP14\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.0, \"API_5x\": 2.6, \"Manual_US\": 5.0, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 2.0, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 125, \"GeneSymbol\": \"PARP14\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.666666666666667, \"API_5x\": 5.6, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 4.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 126, \"GeneSymbol\": \"PARP14\", \"Statements\": \"g. Known drug target\", \"API_3x\": 4.0, \"API_5x\": 4.2, \"Manual_US\": 5.0, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 4.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 127, \"GeneSymbol\": \"PARP14\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 7.0, \"API_5x\": 6.6, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 6.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 128, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 8.0, \"API_5x\": 7.2, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 8.333333333, \"Manual_Qatar\": 7.0, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 129, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 3.0, \"API_5x\": 4.8, \"Manual_US\": 4.666666667, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 130, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 2.0, \"API_5x\": 3.4, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 131, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 7.0, \"API_5x\": 7.0, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 132, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 1.0, \"API_5x\": 2.2, \"Manual_US\": 5.0, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 2.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 133, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.0, \"API_5x\": 5.8, \"Manual_US\": 6.0, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 134, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"g. Known drug target\", \"API_3x\": 0.6666666666666666, \"API_5x\": 1.2, \"Manual_US\": 4.0, \"Manual_Thailand\": 4.333333333, \"Manual_Qatar\": 2.0, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 135, \"GeneSymbol\": \"SAMD9L\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.0, \"API_5x\": 5.8, \"Manual_US\": 6.0, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 136, \"GeneSymbol\": \"SCO2\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 0.6666666666666666, \"API_5x\": 1.4, \"Manual_US\": 0.666666667, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 137, \"GeneSymbol\": \"SCO2\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 0.6666666666666666, \"API_5x\": 1.4, \"Manual_US\": 0.666666667, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 138, \"GeneSymbol\": \"SCO2\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 0.6666666666666666, \"API_5x\": 1.0, \"Manual_US\": 0.666666667, \"Manual_Thailand\": 1.0, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 139, \"GeneSymbol\": \"SCO2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 2.6666666666666665, \"API_5x\": 2.8, \"Manual_US\": 1.333333333, \"Manual_Thailand\": 2.0, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 140, \"GeneSymbol\": \"SCO2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 0.6666666666666666, \"API_5x\": 0.4, \"Manual_US\": 1.0, \"Manual_Thailand\": 3.0, \"Manual_Qatar\": 0.33333333, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 141, \"GeneSymbol\": \"SCO2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 2.3333333333333335, \"API_5x\": 2.8, \"Manual_US\": 1.0, \"Manual_Thailand\": 1.333333333, \"Manual_Qatar\": 0.66666667, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 142, \"GeneSymbol\": \"SCO2\", \"Statements\": \"g. Known drug target\", \"API_3x\": 0.0, \"API_5x\": 0.2, \"Manual_US\": 0.666666667, \"Manual_Thailand\": 2.666666667, \"Manual_Qatar\": 1.0, \"Claude-3\": 1.0}, {\"Unnamed: 0\": 143, \"GeneSymbol\": \"SCO2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 1.3333333333333333, \"API_5x\": 1.8, \"Manual_US\": 0.666666667, \"Manual_Thailand\": 1.666666667, \"Manual_Qatar\": 1.33333333, \"Claude-3\": 2.0}, {\"Unnamed: 0\": 144, \"GeneSymbol\": \"STAT1\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 10.0, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 10.0, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 145, \"GeneSymbol\": \"STAT1\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 9.666666666666666, \"API_5x\": 10.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 9.66666667, \"Claude-3\": 10.0}, {\"Unnamed: 0\": 146, \"GeneSymbol\": \"STAT1\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 8.0, \"API_5x\": 8.0, \"Manual_US\": 9.0, \"Manual_Thailand\": 9.0, \"Manual_Qatar\": 6.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 147, \"GeneSymbol\": \"STAT1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 9.333333333333334, \"API_5x\": 9.0, \"Manual_US\": 10.0, \"Manual_Thailand\": 10.0, \"Manual_Qatar\": 9.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 148, \"GeneSymbol\": \"STAT1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 5.333333333333333, \"API_5x\": 5.2, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 5.0}, {\"Unnamed: 0\": 149, \"GeneSymbol\": \"STAT1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 7.0, \"API_5x\": 7.0, \"Manual_US\": 8.666666667, \"Manual_Thailand\": 7.333333333, \"Manual_Qatar\": 7.0, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 150, \"GeneSymbol\": \"STAT1\", \"Statements\": \"g. Known drug target\", \"API_3x\": 4.666666666666667, \"API_5x\": 5.4, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.333333333, \"Manual_Qatar\": 6.0, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 151, \"GeneSymbol\": \"STAT1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 8.666666666666666, \"API_5x\": 8.8, \"Manual_US\": 9.333333333, \"Manual_Thailand\": 9.0, \"Manual_Qatar\": 9.0, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 152, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.0, \"API_5x\": 8.4, \"Manual_US\": 9.0, \"Manual_Thailand\": 9.0, \"Manual_Qatar\": 8.66666667, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 153, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 5.666666666666667, \"API_5x\": 6.6, \"Manual_US\": 6.0, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 154, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 4.0, \"API_5x\": 4.8, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 6.333333333, \"Manual_Qatar\": 4.0, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 155, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.0, \"API_5x\": 7.6, \"Manual_US\": 7.666666667, \"Manual_Thailand\": 7.666666667, \"Manual_Qatar\": 6.66666667, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 156, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.6666666666666665, \"API_5x\": 2.8, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 157, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 6.666666666666667, \"API_5x\": 5.4, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 5.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 158, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.6666666666666667, \"API_5x\": 1.8, \"Manual_US\": 5.0, \"Manual_Thailand\": 4.666666667, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 159, \"GeneSymbol\": \"TRIM22\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.333333333333333, \"API_5x\": 6.8, \"Manual_US\": 7.0, \"Manual_Thailand\": 7.333333333, \"Manual_Qatar\": 6.33333333, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 160, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"a. Association with type I interferon responses\", \"API_3x\": 9.0, \"API_5x\": 9.0, \"Manual_US\": 9.0, \"Manual_Thailand\": 9.0, \"Manual_Qatar\": 9.0, \"Claude-3\": 9.0}, {\"Unnamed: 0\": 161, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"b. Association with type II interferon responses\", \"API_3x\": 4.666666666666667, \"API_5x\": 6.2, \"Manual_US\": 5.666666667, \"Manual_Thailand\": 6.0, \"Manual_Qatar\": 5.33333333, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 162, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"c. Association with type III interferon responses\", \"API_3x\": 3.3333333333333335, \"API_5x\": 4.6, \"Manual_US\": 6.666666667, \"Manual_Thailand\": 7.0, \"Manual_Qatar\": 4.33333333, \"Claude-3\": 6.0}, {\"Unnamed: 0\": 163, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"API_3x\": 8.0, \"API_5x\": 7.8, \"Manual_US\": 8.333333333, \"Manual_Thailand\": 8.0, \"Manual_Qatar\": 7.33333333, \"Claude-3\": 8.0}, {\"Unnamed: 0\": 164, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"API_3x\": 2.3333333333333335, \"API_5x\": 2.4, \"Manual_US\": 6.333333333, \"Manual_Thailand\": 5.666666667, \"Manual_Qatar\": 2.66666667, \"Claude-3\": 4.0}, {\"Unnamed: 0\": 165, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"API_3x\": 5.666666666666667, \"API_5x\": 5.8, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 6.666666667, \"Manual_Qatar\": 5.0, \"Claude-3\": 7.0}, {\"Unnamed: 0\": 166, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"g. Known drug target\", \"API_3x\": 1.6666666666666667, \"API_5x\": 2.2, \"Manual_US\": 5.333333333, \"Manual_Thailand\": 5.0, \"Manual_Qatar\": 3.33333333, \"Claude-3\": 3.0}, {\"Unnamed: 0\": 167, \"GeneSymbol\": \"ZBP1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"API_3x\": 6.666666666666667, \"API_5x\": 6.8, \"Manual_US\": 7.333333333, \"Manual_Thailand\": 7.333333333, \"Manual_Qatar\": 7.0, \"Claude-3\": 7.0}], \"empty\": [{}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.HConcatChart(...)"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "corrPlot = alt.hconcat(c1,c2,c3).configure_view(strokeWidth=3).configure_axis(grid=False, domain=False)\n",
    "corrPlot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "GeneSymbol\n",
       "DDX58     47.666667\n",
       "DDX60     36.333333\n",
       "DHX58     37.666667\n",
       "FBXO6     18.000000\n",
       "GBP1      44.666667\n",
       "GBP4      35.333333\n",
       "GBP5      42.000000\n",
       "IFI35     37.000000\n",
       "IFIH1     42.333333\n",
       "IFIT2     44.666667\n",
       "IFIT5     39.666667\n",
       "IRF7      47.666667\n",
       "LAP3      20.333333\n",
       "OAS2      47.666667\n",
       "PARP12    33.666667\n",
       "PARP14    42.000000\n",
       "SAMD9L    32.666667\n",
       "SCO2       9.000000\n",
       "STAT1     62.666667\n",
       "TRIM22    44.000000\n",
       "ZBP1      41.333333\n",
       "Name: score, dtype: float64"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dx = benchmarking_m10_1[['GeneSymbol','Statements','API_3x']].rename({'API_3x':'score'},axis=1)\n",
    "dx_sum = dx.groupby('GeneSymbol')['score'].sum()\n",
    "dx_sum"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [],
   "source": [
    "barplot_Scores = alt.Chart(dx).mark_bar().encode(\n",
    "    y=alt.Y('GeneSymbol',sort=list(dx_sum.sort_values().index),axis=alt.Axis(labelFontSize=14)),\n",
    "    x=alt.X('score',axis=alt.Axis(title=\"Total Score\",labelFontSize=14)),\n",
    "    color=alt.Color('Statements',scale=alt.Scale(domain=list(q_color.keys()),range=list(q_color.values())),\n",
    "                    legend=alt.Legend(labelLimit=500)),\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-1f1a7d99ae5b4e888f6749333eea3732.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-1f1a7d99ae5b4e888f6749333eea3732.vega-embed details,\n",
       "  #altair-viz-1f1a7d99ae5b4e888f6749333eea3732.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-1f1a7d99ae5b4e888f6749333eea3732\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-1f1a7d99ae5b4e888f6749333eea3732\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-1f1a7d99ae5b4e888f6749333eea3732\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.16.3?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.16.3\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300}}, \"data\": {\"name\": \"data-8932d0a9992f45888e3dd8414d036695\"}, \"mark\": {\"type\": \"bar\"}, \"encoding\": {\"color\": {\"field\": \"Statements\", \"legend\": {\"labelLimit\": 500}, \"scale\": {\"domain\": [\"a. Association with type I interferon responses\", \"b. Association with type II interferon responses\", \"c. Association with type III interferon responses\", \"d. Relevance to circulating leukocytes immune biology\", \"e. Used as a biomarker in clinical settings\", \"f. Potential value as a blood transcriptional biomarker\", \"g. Known drug target\", \"h. Therapeutically relevant for immune system diseases\"], \"range\": [\"#de2d26\", \"#fc9272\", \"#fee5d9\", \"#756bb1\", \"#74c476\", \"#c7e9c0\", \"#c994c7\", \"#dd1c77\"]}, \"type\": \"nominal\"}, \"x\": {\"axis\": {\"labelFontSize\": 14, \"title\": \"Total Score\"}, \"field\": \"score\", \"type\": \"quantitative\"}, \"y\": {\"axis\": {\"labelFontSize\": 14}, \"field\": \"GeneSymbol\", \"sort\": [\"SCO2\", \"FBXO6\", \"LAP3\", \"SAMD9L\", \"PARP12\", \"GBP4\", \"DDX60\", \"IFI35\", \"DHX58\", \"IFIT5\", \"ZBP1\", \"PARP14\", \"GBP5\", \"IFIH1\", \"TRIM22\", \"IFIT2\", \"GBP1\", \"IRF7\", \"OAS2\", \"DDX58\", \"STAT1\"], \"type\": \"nominal\"}}, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.16.3.json\", \"datasets\": {\"data-8932d0a9992f45888e3dd8414d036695\": [{\"GeneSymbol\": \"DDX58\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 10.0}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.666666666666666}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 6.333333333333333}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"g. Known drug target\", \"score\": 3.3333333333333335}, {\"GeneSymbol\": \"DDX58\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 8.333333333333334}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 8.666666666666666}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.0}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"g. Known drug target\", \"score\": 1.0}, {\"GeneSymbol\": \"DDX60\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 8.666666666666666}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.0}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"g. Known drug target\", \"score\": 1.3333333333333333}, {\"GeneSymbol\": \"DHX58\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.0}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 1.0}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 4.666666666666667}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"g. Known drug target\", \"score\": 1.0}, {\"GeneSymbol\": \"FBXO6\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 9.0}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 4.666666666666667}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.0}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"g. Known drug target\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"GBP1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 6.333333333333333}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.0}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"g. Known drug target\", \"score\": 1.0}, {\"GeneSymbol\": \"GBP4\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 5.0}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 7.333333333333333}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 4.333333333333333}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.333333333333334}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.0}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"g. Known drug target\", \"score\": 1.3333333333333333}, {\"GeneSymbol\": \"GBP5\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 8.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 5.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 6.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"g. Known drug target\", \"score\": 1.0}, {\"GeneSymbol\": \"IFI35\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 5.0}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.333333333333334}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.0}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.0}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"g. Known drug target\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"IFIH1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 7.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.333333333333334}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 5.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 5.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.666666666666667}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 3.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 6.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"g. Known drug target\", \"score\": 2.0}, {\"GeneSymbol\": \"IFIT2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.0}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 4.0}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 4.333333333333333}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.0}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"g. Known drug target\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"IFIT5\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 10.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 6.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.666666666666666}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 4.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 6.333333333333333}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"g. Known drug target\", \"score\": 2.0}, {\"GeneSymbol\": \"IRF7\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 7.666666666666667}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 2.0}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 1.0}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 5.0}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 3.3333333333333335}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"g. Known drug target\", \"score\": 1.3333333333333333}, {\"GeneSymbol\": \"LAP3\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 3.0}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.666666666666666}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 5.0}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.333333333333334}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 3.0}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 7.0}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"g. Known drug target\", \"score\": 2.0}, {\"GeneSymbol\": \"OAS2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 7.333333333333333}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 7.666666666666667}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.6666666666666665}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 6.333333333333333}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 1.3333333333333333}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.0}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"g. Known drug target\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"PARP12\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 4.666666666666667}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 7.0}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 5.0}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.3333333333333335}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.0}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.0}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"g. Known drug target\", \"score\": 4.0}, {\"GeneSymbol\": \"PARP14\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 7.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 8.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 3.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 2.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 7.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 1.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.0}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"g. Known drug target\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"SAMD9L\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.0}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 0.6666666666666666}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"g. Known drug target\", \"score\": 0.0}, {\"GeneSymbol\": \"SCO2\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 1.3333333333333333}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 10.0}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 9.666666666666666}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 8.0}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 9.333333333333334}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 5.333333333333333}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 7.0}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"g. Known drug target\", \"score\": 4.666666666666667}, {\"GeneSymbol\": \"STAT1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 8.666666666666666}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.0}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 4.0}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.0}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.6666666666666665}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 6.666666666666667}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"g. Known drug target\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"TRIM22\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.333333333333333}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"a. Association with type I interferon responses\", \"score\": 9.0}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"b. Association with type II interferon responses\", \"score\": 4.666666666666667}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"c. Association with type III interferon responses\", \"score\": 3.3333333333333335}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"d. Relevance to circulating leukocytes immune biology\", \"score\": 8.0}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"e. Used as a biomarker in clinical settings\", \"score\": 2.3333333333333335}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"f. Potential value as a blood transcriptional biomarker\", \"score\": 5.666666666666667}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"g. Known drug target\", \"score\": 1.6666666666666667}, {\"GeneSymbol\": \"ZBP1\", \"Statements\": \"h. Therapeutically relevant for immune system diseases\", \"score\": 6.666666666666667}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.Chart(...)"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "barplot_Scores"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "py3_10",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
